Organization and Business - Additional Information (Detail) (USD $)	6 Months Ended	12 Months Ended	62 Months Ended
	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2010
Organization and Nature of Operations [Line Items]
Impairment of License	$ 345,000	$ 345,000	$ 690,000
Percentage of Charge		50.00%
Cash	162,440	952,252	162,440	1,221,659	238,565
Common Stock
Organization and Nature of Operations [Line Items]
Cash	235,000		235,000
Private Placement memorandum | Common Stock | Minimum
Organization and Nature of Operations [Line Items]
Cash	1,000,000		1,000,000
Private Placement memorandum | Common Stock | Maximum
Organization and Nature of Operations [Line Items]
Cash	2,000,000		2,000,000
Phase I clinical trial
Organization and Nature of Operations [Line Items]
Number patients benefited from Liposomal Grb-2 treatment	3		3
Phase I clinical trial | Minimum
Organization and Nature of Operations [Line Items]
Number of evaluable patients in Phase I Clinical trial	18
Cost to completion of Phase-I-Clinical trial	400,000		400,000
Phase I clinical trial | Maximum
Organization and Nature of Operations [Line Items]
Number of evaluable patients in Phase I Clinical trial	30
Cost to completion of Phase-I-Clinical trial	$ 550,000		$ 550,000